Systemic Bevacizumab Therapy in Recurrent Respiratory Papillomatosis: First Preliminary Study From Azerbaijan.

Hashimli R, Aliyeva A.

Open source

DOI
10.1002/lio2.70395
Published
2026-04-07
Container
Laryngoscope Investig Otolaryngol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/lio2.70395,
  title = {Systemic Bevacizumab Therapy in Recurrent Respiratory Papillomatosis: First Preliminary Study From Azerbaijan.},
  author = {Hashimli R and  Aliyeva A.},
  year = {2026},
  journal = {Laryngoscope Investig Otolaryngol},
  doi = {10.1002/lio2.70395},
  url = {https://doi.org/10.1002/lio2.70395}
}

RIS

TY  - JOUR
TI  - Systemic Bevacizumab Therapy in Recurrent Respiratory Papillomatosis: First Preliminary Study From Azerbaijan.
AU  - Hashimli R
AU  -  Aliyeva A.
PY  - 2026
JO  - Laryngoscope Investig Otolaryngol
DO  - 10.1002/lio2.70395
UR  - https://doi.org/10.1002/lio2.70395
ER  - 

APA

R, H., & A., A. (2026). Systemic Bevacizumab Therapy in Recurrent Respiratory Papillomatosis: First Preliminary Study From Azerbaijan.. Laryngoscope Investig Otolaryngol. https://doi.org/10.1002/lio2.70395

Source records